These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke. Al-Khaled M; Matthis C; Eggers J J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915 [TBL] [Abstract][Full Text] [Related]
5. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A; Dzialowski I; Koch R; Gahn G J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668 [TBL] [Abstract][Full Text] [Related]
6. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC; Rabinstein AA Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870 [TBL] [Abstract][Full Text] [Related]
7. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877 [TBL] [Abstract][Full Text] [Related]
8. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Lansberg MG; Albers GW; Wijman CA Cerebrovasc Dis; 2007; 24(1):1-10. PubMed ID: 17519538 [TBL] [Abstract][Full Text] [Related]
9. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Gumbinger C; Gruschka P; Böttinger M; Heerlein K; Barrows R; Hacke W; Ringleb P Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049 [TBL] [Abstract][Full Text] [Related]
10. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era. Takayanagi S; Ochi T; Hanakita S; Suzuki Y; Maeda K Neurol Med Chir (Tokyo); 2014 Jun; 54(6):435-40. PubMed ID: 24670312 [TBL] [Abstract][Full Text] [Related]
11. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099 [TBL] [Abstract][Full Text] [Related]
12. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms. Sheth KN; Shah N; Morovati T; Hermann LD; Cronin CA Neurocrit Care; 2012 Oct; 17(2):199-203. PubMed ID: 22752394 [TBL] [Abstract][Full Text] [Related]
13. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333 [TBL] [Abstract][Full Text] [Related]
14. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192 [TBL] [Abstract][Full Text] [Related]
15. Hemorrhagic complications of thrombolytic therapy. Vujković Z; Racić D; Miljković S; Dajić V Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232 [TBL] [Abstract][Full Text] [Related]
16. Low-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry. Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Endo K; Miyagi T; Osaki M; Minematsu K; Toyoda K Stroke; 2012 Jan; 43(1):253-5. PubMed ID: 21960585 [TBL] [Abstract][Full Text] [Related]